Biotech company CureVac aims to raise up to $245 million in U.S. IPO
FRANKFURT (Reuters) – CureVac, one of Germany’s leading contenders to develop a COVID-19 vaccine, said it aims to raise up to $245 million [...]
Home »
CureVac aims to raise up to $245 million in U.S. IPO
FRANKFURT (Reuters) – CureVac, one of Germany’s leading contenders to develop a COVID-19 vaccine, said it aims to raise up to $245 million [...]